BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use.


Updates from The Motley Fool

Latest updates on BioTime from Fool.com.
3 Reasons Behind Geron's Rebound

Geron (NASDAQ: GERN) has had a wild ride this year, bouncing between a 52-week low of $0.98 in Ap...

The Worst of 2012: BioTime

It's the end of 2012, and that means it's time to take a look back at the year in retrospect. We'...

The Bearish Case for BioTime

Sid Haksar manages a concentrated, value-oriented investment partnership inspired by the 1950s Bu...



Stock Performance

View Interactive BTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about BioTime.
Current Price: $3.18
Prev Close: $3.24
Open: $3.20
Bid: $2.91
Ask: $3.20
Day's Range: $3.15 - $3.25
52wk Range: $2.02 - $4.10
Volume: 128,820
Avg Vol 231,081
Market Cap: $302M
P/E (ttm): 14.09
EPS (ttm): $0.23
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about BioTime.
CAPS Rating 2 out of 5
 
60 Outperform
38 Underperform
CAPS All Stars
 
2 Outperform
15 Underperform

How do you think BioTime will perform against the market?



You pick for BioTime is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael D. West, CEO

62% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for BioTime.

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers